AccessibilityHelpAbout Us
BlackRock Health Sciences Trust logo

BlackRock Health Sciences Trust(NYSE) BME

Market Cap$579.52MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2005)+911%
5 Year+31%
1 Year+34%
1 Month-3%
$44.84
-0.31%
-0.14Today
BlackRock Health Sciences Trust last closing stock price
MetricPriceDate
Last closeUSD 44.842026-09-25
BlackRock Health Sciences Trust stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.79%USD 44.492026-09-18
1 month-2.54%USD 46.012026-08-26
3 month+7.65%USD 41.652026-06-26
Year to date+15.38%USD 38.862025-12-31
1 year+34.28%USD 33.392025-09-25
3 year+43.41%USD 31.272023-09-26
5 year+30.69%USD 34.312021-09-24
Since inception+910.93%USD 4.442005-03-29

BlackRock Health Sciences Trust Financials at a Glance

Market Cap

$579.52MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$94.17M

Net Income (TTM)

$77.95M

EPS (TTM)

$8.05

P/E Ratio

5.57

Dividend

$3.15

Beta (Volatility)

0.48 (Low)

Price

$44.84

Volume

27,687.056

Open

$44.95

Previous Close

$44.84

Daily Range

$44.71 - $44.95

52-Week Range

$36.21 - $46.43

Estimated Earnings Date

N/A

BME News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust is a closed-ended equity mutual fund managed by BlackRock Advisors, LLC. The fund focuses on investing in public equity markets within the health sciences sector, targeting companies involved in medical, dental, optical, pharmaceutical, and biotechnology products and services.

Products and Services
  • Invests in health sciences companies across various sub-sectors
  • Utilizes equity derivatives with an emphasis on option writing
  • Benchmarks performance against the Russell 3000 Healthcare Index
Growth Outlook
  • Recent quarterly revenue reached $30.75 million, showing strong performance
  • Trailing twelve months (TTM) revenue of $113.5 million indicates consistent growth
  • Dividend yield of 7.07% reflects attractive returns for investors
Financial Highlights
  • Net income for Q2 2026 was $23.48 million, showcasing profitability
  • Operating income margin of 76.41% highlights operational efficiency
  • Low debt ratio of 0.0012 suggests strong financial stability
BlackRock Health Sciences Trust offers a unique investment opportunity within the health sciences sector, capitalizing on the growing demand for healthcare solutions. The fund's strategic focus on high-potential companies positions it well for future growth, particularly as the healthcare industry continues to evolve. Recent financial performance underscores the fund's ability to generate substantial revenue and maintain profitability, making it an appealing option for investors seeking exposure to the health sciences market. The strong dividend yield further enhances its attractiveness, providing a steady income stream alongside potential capital appreciation.
AI Generated • Sep 18, 2026

Industry

Capital Markets

Sector

Financials

CEO

John M. Perlowski, CPA

Headquarters

New York, NY 10001, US

BME Financials

Key Financial Metrics (TTM)

Gross Margin

89.50%

Operating Margin

194.48%

Net Income Margin

194.41%

Return on Equity

18.25%

Return on Capital

13.53%

Return on Assets

18.10%

Earnings Yield

17.95%

Dividend Yield

7.01%

Payout Ratio

39.05%

Stock Overview

Market Cap

$579.52MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

12.92M

Volume

27.69K

Avg. Volume

43.71K

Financials (TTM)

Gross Profit

$85.29M

Operating Income

$82.55M

EBITDA

$82.55M

Operating Cash Flow

$19.12M

Capital Expenditure

-$3.00

Free Cash Flow

$19.12M

Cash & ST Invst.

$19.73M

Total Debt

$688.35K

BlackRock Health Sciences Trust Performance Analysis

BlackRock Health Sciences Trust annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 21,403,690-59.8%
20232023-12-31USD 34,895,72563.0%
20242024-12-31USD 36,328,2794.1%
20252025-12-31USD 36,159,448-0.5%
BlackRock Health Sciences Trust sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-319664.0%
Q22025-06-30-89.2%
Q42025-12-31475.0%
Q22026-06-3035.1%
BlackRock Health Sciences Trust annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -1.91N/A
20232023-12-31USD 1.44N/A
20242024-12-31USD 1.7723.3%
20252025-12-31USD 5.92234.6%
BlackRock Health Sciences Trust sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-151.5%
Q22025-06-3083.5%
Q42025-12-312325.0%
Q22026-06-30-70.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$30.75M

+8110.2%

Gross Profit

$28.00M

+906.8%

Gross Margin

91.05%

N/A

Market Cap

$579.52MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$23.48M

-48.9%

EBITDA

$23.49M

-48.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$19.73M

+1732533.5%

Total Debt

$688.35K

-33.9%

Accounts Receivable

$2.58M

-18.5%

Inventory

$0.00

N/A

Long Term Debt

$687.78K

N/A

Short Term Debt

$569.00

-95.6%

Return on Assets

18.10%

N/A

Return on Invested Capital

18.11%

N/A

Free Cash Flow

-$9.45M

-440.1%

Operating Cash Flow

-$9.45M

-440.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BHKBlackRock Core Bond Trust
$8.37+1.33%
BGYBlackRock Enhanced International Dividend Trust
$5.77+0.87%
BLEBlackRock Municipal Income Trust II
$10.54-0.19%
DPGDuff & Phelps Utility and Infrastructure Fund Inc.
$12.92-0.15%

Trending Stocks

Symbol / CompanyPricePrice Chg
GLNDGreenland Energy
$5.54+3.55%
INTCIntel
$123.00-3.45%
NVDANvidia
$225.07+0.22%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.94-3.02%

Questions About BME

What is the current price of BlackRock Health Sciences Trust?

BlackRock Health Sciences Trust is trading at $44.84 per share.

What is the 52-week range for BlackRock Health Sciences Trust?

Over the past 52 weeks, BlackRock Health Sciences Trust has traded between $36.21 and $46.43.

How much debt does BlackRock Health Sciences Trust have?

As of the most recent reporting period, BlackRock Health Sciences Trust reported total debt of $894.33K.

How much cash does BlackRock Health Sciences Trust have on hand?

BlackRock Health Sciences Trust reported $548.00 in cash and cash equivalents in its most recent financial results.

What is BlackRock Health Sciences Trust’s dividend yield?

BlackRock Health Sciences Trust currently has a dividend yield of 7.01%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services